About: Pentostatin     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz:8890 associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Pentostatin
equivalentClass
Concept_In_Subset
Semantic_Type
  • Antibiotic
  • Nucleic Acid, Nucleoside, or Nucleotide
Preferred_Name
  • Pentostatin
NSC_Code
  • 218321
  • 247520
UMLS_CUI
  • C0030896
CAS_Registry
  • 53910-25-1
  • 63677-95-2
Accepted_Therapeutic_Use_For
  • Chronic lymphocytic leukemia; Cutaneous t-cell lymphoma; Hairy cell leukemia
In_Clinical_Trial_For
  • Chronic lymphocytic leukemia; Graft versus Host disease; Lymphoid malignancies; Non-Hodgkins lymphoma; Renal cell cancer
FDA_UNII_Code
  • 395575MZO7
Contributing_Source
  • FDA
ALT_DEFINITION
  • The active ingredient in a drug that is used to treat hairy cell leukemia and is being studied in the treatment of other types of cancer. Pentostatin blocks a protein needed for cell growth and may kill cancer cells. It is made by a bacterium. It is a type of adenosine deaminase inhibitor.NCI-GLOSS
PDQ_Open_Trial_Search_ID
  • 39210
PDQ_Closed_Trial_Search_ID
  • 39210
Chemical_Formula
  • C11H16N4O4
Legacy_Concept_Name
  • Pentostatin
FULL_SYN
  • PentostatinPTNCI
  • CovidarabineSYDTPNSC0218321
  • (R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-olSNNCI
  • CovidarabineSYNCI
  • PentostatineSYNCI
  • Co-VidarabineSYNCI
  • Co-vidarabineSYDTPNSC0247520
  • pentostatinPTNCI-GLOSSCDR0000045190
  • DCFABNCI
  • DeoxycoformycinSYNCI
  • NipentPTNCI-GLOSSCDR0000618582
  • CI-825CNNCI
  • NipentBRNCI
  • 2'-DeoxycoformycinSYNCI
  • (R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7, 8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-olSYDTPNSC0247520
  • PD-81565CNNCI
  • PENTOSTATINPTFDA395575MZO7
  • PENTOSTATINSYDTPNSC0247520
  • 2'-DeoxycoformycinSYDTPNSC0247520
DEFINITION
  • A purine nucleotide analogue antibiotic isolated from the bacterium Streptomyces antibioticus. Also known as 2'-deoxycoformycin, pentostatin binds to and inhibits adenine deaminase (ADA), an enzyme essential to purine metabolism; ADA activity is greatest in cells of the lymphoid system with T-cells having higher activity than B-cells and T-cell malignancies higher ADA activity than B-cell malignancies. Pentostatin inhibition of ADA appears to result in elevated intracellular levels of dATP which may block DNA synthesis through the inhibition of ribonucleotide reductase. This agent may also inhibit RNA synthesis and may selectively deplete CD26+ lymphocytes. (NCI04)NCI
code
  • C732
sameAs
http://linked.open...y/mesh/hasConcept
is someValuesFrom of
is sameAs of
Faceted Search & Find service v1.16.121 as of Mar 31 2025


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3240 as of Mar 31 2025, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 14 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software